Monitoring exposure of Western Victorian farmers to organophosphate pesticides
In-field Personalised Cholinesterase Assessment Project (In-field PCAP): Monitoring Victorian farmers exposed to agricultural pesticides in workplace
Deakin University
50 participants
Apr 4, 2016
Observational
Conditions
Summary
Aims: This study aims to develop the methodology for clinical point of care (POC) sampling to determine the level of exposure to organophosphates (OP’s) by western Victorian farmers. Significance: This methodology will test for cholinesterase activity and provide the basis for future research work by identifying the potential chemical exposure pathways of individuals most at risk in farming communities. Expected outcomes: The study will provide a methodology for cholinesterase activity measurement in farmers and the possible integration of POC sampling in farmer health checks. Importantly it will highlight pesticide contact as a risk for farmers, leading to further research to quantify pesticide exposure both on the farm and in the home of farming families.
Eligibility
Plain Language Summary
Simplified for easier understanding
This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Target Population: Western Victorian farmers and agricultural workers engaged in crop and livestock operations, with self-reported use of agrichemicals and cholinesterase inhibiting insecticides. By measuring the activity of the enzyme cholinesterase, exposure to organophophates can be identified. Enzyme activity will be monitored every 4 weeks over the 12 months period. Each participant will receive a baseline health check during the first visit including: a) Measurements: Height, weight, waist and hip circumference, body fat percentage, blood pressure, pulse rate. b) Capillary blood sample : Collected using a finger prick, will test for : Fasting blood glucose, establish personal quantitative estimates of both red blood cell ChE and Plasma ChE. c) Health and Chemical usage survey: Complete chemical use and well being questionnaire For the subsequent visits, each participant will undergo: a) Capillary blood sample: Individualised cholinesterase activity level measured , recorded and discussed by registered nurse. b) Health and Chemical usage survey: Chemical use and well being questionnaire
Locations(3)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12616001130459